期刊文献+

玄参滴丸制备工艺及质量标准研究 被引量:2

Study on Preparation Technology and Quality Standard of Xuanshen Dropping Pills
原文传递
导出
摘要 目的确定玄参滴丸最佳制备工艺并制定其质量标准。方法以滴丸的溶散时限、外观及丸重变异系数作为综合评定指标,对玄参提取物与基质的比例、基质配比(PEG4000:PEG6000)、药液温度及滴制过程中滴速、滴距、冷凝液温度进行正交试验设计,优选出滴丸最佳成型工艺及滴制工艺。采用TLC对玄参滴丸进行定性鉴别,超高效液相色谱法(UPLC)测定玄参滴丸中哈巴俄苷的含量。色谱柱:ACQUITYUPLCBEHC18柱(2.1mm×100mm,5um);流动相:乙腈-1%醋酸(31:69);柱温:35℃;流速:0.2mL·min-1;检测波长:278am。结果以药物-基质(1:3),PEG4000-PEG6000(4:1),药液温度90℃,冷凝液为二甲基硅油和液体石蜡混合液为最佳成型工艺;滴速(20±21滴·min-1,滴距3cm,冰水浴冷却为最佳滴制工艺。TLC可以很好地鉴别滴丸中的主要成分,哈巴俄苷在0.010~0.040μg内呈良好的线性关系,r=0.9999,平均回收率为99.2%,RSD为0.87%。结论本试验制得的滴丸溶散时限、外观及丸重均符合质量要求,制备方法简便可行。含量测定方法操作简便、专属性强、重复性好、结果准确可靠,可用于玄参滴丸的质量控制。 OBJECTIVE To establish an optimum preparation technology and the method for quality control of Xuanshen dripping pills. METHODS Orthogonal test was applied to optimize the preparation with the choice of substrate, its proportion of substrate to drug, the drug and refrigerant temperature, dropping speed and distance to make dissolution time, appearance and weight variation up to grade. Using TLC to identify the dr/pping pills, harpagoside in dripping pills was determined by UPLC. Using ACQUITY UPLC BEH C18 column (2.1 mm × 100 mm, 5μm), the mobile phase was acetonitrile- 1% ethylic acid (31 : 69), the column temperature was 35℃, the flow rate was 0.2 mL.min-1 and the detection wavelength was 278 nm. RESULTS The optimum pills preparation was the ratio of PEG4000 to PEG6000 (4 : 1) and drug to substrate (1 : 3). Drug temperature was 90℃. The mixed liquid of dimethicone and liquid paraffin was refrigerant. Drug was dropped into the refrigerant of 0℃ by (20±2) dropping per minute (freeze-pillar height 3 cm). The herbs could be identified by TLC. For harpagoside, the linear range was 0.010-0.040μg(r=0.999 9), and the average recovery was 99.2%, RSD was 0.87%. CONCLUSION The good quality pills can be produced through this process with the simple and reliable method. The determination method is simple, specific,reproducible and accurate, and can be applied to the quality control for the Xuanshen dripping pills.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2011年第8期724-729,共6页 Chinese Journal of Modern Applied Pharmacy
基金 浙江省中医药管理局重点项目(2007ZA003) 浙江省卫生高层次创新人才培养项目
关键词 玄参滴丸 制备工艺 质量标准 Xuanshen dripping pills preparation technology quality standard
  • 相关文献

参考文献8

二级参考文献41

共引文献228

同被引文献19

  • 1倪正,蔡雪珠,黄一平,王殿俊,卞慧敏.玄参提取物对大鼠血液流变性、凝固性和纤溶活性的影响[J].微循环技术杂志(临床与实验),2004,8(5):339-339. 被引量:6
  • 2黄国栋,李家邦,黄媛华,黄道富,唐丽君,张曙,李倩.青藤碱治疗类风湿关节炎100例临床研究[J].中国中医急症,2007,16(4):416-417. 被引量:16
  • 3俞静静,陈素红,吕圭源.玄参“凉血滋阴”药效相关研究概况[J].中国实验方剂学杂志,2007,13(9):63-66. 被引量:59
  • 4钟晓明.一种抗脑缺血玄参的有效成分提取及滴丸制备方法[P].ZL200910155688.X,2011-11-23.
  • 5Harukuni I, Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia[ J ]. Neurol Clin, 2006,24 ( 1 ) : 1- 21.
  • 6KAA SIK A, KALDA A, JAA KO K, et al. Dehydroepi- androsterone sulphate prevents oxygen-glucose deprivation- induced injury in cerebellar granule cell culture [ J ]. J Neurosci ,2001,102 ( 2 ) :427-432.
  • 7SCORZIELLO A, PELLEG RINI C, FORTEL, et al. Differ- ential vulnerability of cortical and cerebellar neurons in pri- mary culture to oxygen glucose deprivation followed by reoxvenation [ J]..I Neurosci Res ,2001,63 ( 1 ) :20-26.
  • 8Hao Yang, Rui Cong, Luo Na, et al. Long-Term Primary Culture of Highly-Pure Rat Embryonic Hippocampal Neu- rons of Low-Density [ J ]. Neurochem Res, 2010,35 : 1333- 1342.
  • 9Malagelada C, Xifr6 X, Mifiano A, et al. Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures [ J ]. Neurobiol Dis, 2005,20 ( 1 ) :27-37.
  • 10Canas PT, Velly LJ, Labrande CN, et aL Sevoflurane pro- tects rat mixed cerebrocortical neuronalglial cell cultures against transient oxygen-glucose deprivation:involvement of glutamate uptake and reactive oxygen species [ J ]. Anes- thesiology, 2006,105 (5) :990-998.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部